Pharmacology - Mock Test 3

Question 21

The primary indication of tamoxiphen citrate is

A) Female infertility B) Endometrial carcinoma C) Carcinoma breast D) Endometriosis

---

No Details

Question 22

Benefits of tamoxifen citrate therapy include the following except

A) Reduction in recurrence rate of breast cancer B) Improved bone mass C) Suppression of menopausal hot flushes D) Improved lipid profile

---

No Details

Question 23

What is <u>true</u> of tamoxifen

A) It can induce endometrial proliferation in postmenopausal women B) It exerts antiestrogenic activity in bone C) It raises LDL-cholesterol levels D) It is ineffective in estrogen receptor-negative breast cancer

---

No Details

Question 24

Which of the following is a selective estrogen receptor modulator that improves bone mineral density in postmenopausal women

A) Clomiphene citrate B) Raloxifene C) Ormeloxifene D) Alendronate

---

No Details

Question 25

The following is an orally active ovulation inducing agent

A) Menotropin B) Mifepristone C) Danazol D) Clomiphene citrate

---

No Details

Question 26

For the treatment of female infertility, clomiphene citrate is used in the following manner

A) Daily from 5th to 10th day of menstrual cycle B) On alternate days over the last two weeks of menstrual cycle C) Cyclically for 3 weeks with one week gap D) Continuously till conception occurs

---

No Details

Question 27

Clomiphene citrate is indicated for the following condition/conditions

A) Female infertility due to anovular cycles B) Male infertility due to oligozoospermia C) Endometriosis D) Both 'A' and 'B'

---

No Details

Question 28

In women of child bearing age, clomiphene citrate produces the following actions except

A) Hot flushes B) Ovulation C) Decreased FSH and LH secretion D) Polycystic ovaries

---

No Details

Question 29

Estrogen replacement therapy for postmenopausal women is contraindicated in subjects with

A) Leg vein thrombosis B) Undiagnosed vaginal bleeding C) Migraine D) All of the above

---

No Details

Question 30

Estrogens are palliative in the following malignancy

A) Carcinoma breast B) Carcinoma cervix C) Endometrial carcinoma D) Carcinoma prostate

---

No Details